Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)

NCT03829878 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study not started

Conditions

Autism Spectrum Disorder
Autism
ASD
Autistic Thinking
Autistic Behavior
Finch
FMT
Fecal Microbiota Transplant
CP101
SPROUT
Fecal Transplant

Interventions

DRUG: CP101
DRUG: Placebo

Sponsor

Finch Research and Development LLC.